Table 5.
Studies Reporting Other Ocular Disease as Part of a Diabetic Retinopathy Screening Study Using Telemedicine
| CURRENT STUDY | OWSLEY ET AL.8 | CAVALLERANO ET AL.9 | MASSIN ET AL.10 | JIVRAJ ET AL.11 | |||
|---|---|---|---|---|---|---|---|
| 53% White | 62% AA | ||||||
| Primary Ethnicity | 18% AA | 15% Hispanic | Race not reported | French | Northwest Cameroon | ||
| 17% AI/AN | 12% White | ||||||
| 51.1 | 54.4 | 63.2 | 59.9 | 54.2 | |||
| Average age | Per eye | Per person | Per person | Per eye | Per person | Per eye | Per eye unless specified |
| Diabetic retinopathy | |||||||
| Total diabetic retinopathy | 17.4% (143/820) | 24.5% (104/424) | 21.7% (NRa) | 26.8% (327/1219) | 30.5% (207/679) | 18.0% (91/506) | 22.7% (197/868 persons) |
| Mild nonproliferative | 13.9% (114/820) | 18.4% (78/424) | 18.8% (229/1219) | 20.8% (141/679) | 10.2% (52/506) | NR | |
| Moderate nonproliferative | 3.2% (26/820) | 4.0% (17/424) | 4.2% (51/1219) | 5.5% (37/679) | 5.3% (27/506) | NR | |
| Severe nonproliferative | 0.00% | Different definition used | 2.7% (33/1219) | 2.7% (18/679) | 0% | NR | |
| Proliferative | 1.6% (13/820) | 2.1% (9/424) | 1.1% (14/1219) | 1.6% (11/679) | 2.4% (12/506) | 0.2% (2/868 persons) | |
| Cataract | NR | 30.7% (581/1894) | 30.7% (749/2437) | 58.2% (395/679) | NR | 29.6% (150/506) | |
| Hypertensive retinopathy | NR | 16.7% (316/1894) | 1.3% (32/2437) | 3.0% (20/679) | 0.1% (2/1819) | NR | |
| Cotton-wool spots | NR | 11.1% (211/1894) | NR | NR | NR | NR | |
| Glaucoma suspect | 6.8% (56/820) | 10.4% (44/424) | 10.4% (197/1894) | 9.6% (233/2437) | 22.4% (152/679) | 0.2% (3/1819) | 3.6% (18/506) |
| ARMD (or macular drusen/RPE changes) | 3.8% (31/820) | 2.8% (12/424) | 9.2% (174/1894) | 5.6% (136/2437) | 3.8% (26/679) | 0.2% (3/1819) | 2.2% (11/506) |
| Pterygium | NR | 4.8% (90/1894) | 0.5% (14/2437) | 1.8% (12/679) | NR | 1.2% (6/506) | |
| Nevus | 0.4% (3/820) | 0.7% (3/424) | 0.6% (11/1894) | NR (reported along with other lesions) | NR (reported along with other lesions) | NR | NR |
| Vascular occlusion | 0.2% (2/820) | 0.5% (2/424) | ≤0.26% (≤5/1894) | 0.3% (7/2437) | 0.9% (6/679) | NR | 1.6% (8/506) |
| Epiretinal membrane | 0.2% (2/820) | 0.5% (2/424) | ≤0.26% (≤5/1894) | 1.4% (35/2437) | 4.7% (32/679) | NR | NR |
| Chorioretinal scar/atrophy | 0.1% (1/820) | 0.2% (1/420) | ≤0.26% (≤5/1894) | 0.6% (14/2437) | 2.1% (14/679) | NR | NR |
| Retinal detachment | NR | NR | 0.04% (1/2437) | 0.2% (1/679) | NR | 0.6% (3/506) | |
NR, not reported; RPE, retinal pigment epithelium.